Type
- ARTG (96)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (13)
- Prescription medicine evaluation (3)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Cancellation or suspension (1)
Sponsor content
166 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYALTRIS ALLERGY olopatadine (as hydrochloride) 600 microgram/actuation and mometasone furoate (as monohydrate) 25 microgram/actuation nasal spray bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bulk trivalent influenza vaccine (surface antigen, prepared in cell cultures).
-
Australian public assessment report (AusPar)Audenz (influenza virus haemagglutinin) is indicated for active immunisation against influenza A in persons from 6 months of age and older in an officially declared pandemic.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Q-VAX Q FEVER VACCINE 0.5mL suspension for injection vial.
-
Australian public assessment report (AusPar)Calcemic is indicated for active immunisation against the H5 subtype of Influenza A virus in persons from 6 months of age and older. Celldemic should be used in accordance with official recommendations.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERIVO iron (as ferric carboxymaltose) 100mg/2mL injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERIVO iron (as ferric carboxymaltose) 1000 mg/20 mL injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERIVO iron (as ferric carboxymaltose) 500 mg/10 mL injection vial.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NEFFY adrenaline (epinephrine) 1 mg nasal spray vial.